×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
|
Dashboard
Analyses
Exchange
Gaps
←
Home
/
Wiki
/
Therapeutic: siRNA and RNA Therapeutics Brain Delivery
therapeutic
1,407 words
KG: siRNA
Contents
siRNA and RNA Therapeutics Brain Delivery
💊
Therapeutic Info
Name
siRNA
Key Genes/Proteins
APOE
,
SETX
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
LRP1-Dependent Tau Uptake Disruption
Score: 0.58
Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.73
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Smartphone-Detected Motor Variability Correction
Score: 0.74
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
TREM2-Dependent Microglial Senescence Transition
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.92
Transcriptional Autophagy-Lysosome Coupling
Score: 0.88
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.85
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.81
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
Phase-Separated Organelle Targeting
Score: 0.73
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Show 25 more
Related Analyses (30)
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Show 25 more
Related Experiments (1)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
See Also (15)
SETX Gene
gene · KG edge: targets
APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: inhibits
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 5 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 5 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 5 hypotheses
Blood-Brain Barrier Dysfunction and Therapeutic Deliver
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 5 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 5 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 5 hypotheses
Geniposide for Alzheimer's disease - immune biomarker t
mechanism · Pages share 5 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 5 hypotheses
Show 10 more
Knowledge Graph (2 edges)
siRNA
inhibits
APOE
siRNA
targets
SETX
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)